Fabio Benedetti Md Apollomics Inc

Fabio Benedetti Md Apollomics Inc
Fabio Benedetti Md Apollomics Inc

Fabio benedetti, md. chief medical officer. management. dr. benedetti joined apollomics in may 2019 with over 20 years industry experience in oncology clinical development and medical affairs. prior to joining apollomics, dr. benedetti was global chief medical officer at taiho pharmaceutical company, ltd. in tokyo, japan where he ran a global. View fabio benedetti md’s profile on linkedin, the world's largest professional community. fabio has 9 jobs listed on their profile. fabio benedetti md chief medical officer apollomics, inc. Foster city, ca, and hangzhou, china, 1 may 2019 — apollomics, inc. (the “company”), an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies, today announced that fabio m. benedetti, m.d. has joined the senior leadership team as chief medical officer (cmo), effective today.dr. benedetti will lead the company’s global clinical. Foster city, calif. and hangzhou, china, may 01, 2019 apollomics, inc. (the “company”), an innovative biopharmaceutical company committed to the discovery. Fabio m benedetti is chief medical officer at apollomics inc. see fabio m benedetti's compensation, career history, education, & memberships.

Fabio Albanini Alla Guida Di Snom Technology Italia Sab
Fabio Albanini Alla Guida Di Snom Technology Italia Sab

Foster city, ca, and hangzhou, china, 1 may 2019 — apollomics, inc. (the “company”), an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies, today announced that fabio m. benedetti, m.d. has joined the senior leadership team as chief medical officer (cmo), effective today. dr. benedetti will lead the company’s global. Contact us apollomics, inc. 989 east hillsdale blvd. ste 220 foster city, ca 94404 usa 1.925.272.4090 phone 1.925.272.4094 fax. Apollomics us headquarters. 989 east hillsdale blvd, suite 220 foster city, ca 94404 usa. tel: 1.650.209.4055 fax: 1.650.288.1674. Apollomics, inc. appoints fabio m. benedetti, m.d. as chief medical officer. april 1, 2019 apollomics, inc. presents positive preclinical data on apl 102, an oral multi kinase inhibitor with csf 1r activity. january 22, 2019 apollomics, inc. strengthens leadership with key hires. Fabio benedetti, md: apollomics (australia) pty. ltd. more information. go to top of page study description study design arms and interventions outcome measures eligibility criteria contacts and locations more information. additional information: company website for apollomics inc.

Related image with fabio benedetti md apollomics inc

Related image with fabio benedetti md apollomics inc

Scroll Up